Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | FBP1 | P09467 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25766831 | 0.83 | TSHR (0.37) | BTN3A1TSHRKDM4EALDH1A1CA12 | |
| SCHEMBL25766390 | 0.81 | TP53 (0.36) | BTN3A1TSHRKDM4EALDH1A1CA12 | |
| SCHEMBL28275107 | 0.81 | BTN3A1 (0.37) | BTN3A1TSHRKDM4EALDH1A1CA12 | |
| SCHEMBL16991699 | 0.81 | BTN3A1 (0.37) | BTN3A1TSHRKDM4EALDH1A1CA12 | |
| SCHEMBL26367006 | 0.80 | ALDH1A1 (0.43) | TSHRKDM4EALDH1A1CA12CA1 | |
| SCHEMBL16026166 | 0.80 | PPARG (0.36) | BTN3A1TSHRKDM4EALDH1A1CA12 | |
| SCHEMBL18563093 | 0.80 | PPARG (0.36) | BTN3A1TSHRKDM4EALDH1A1CA12 | |
| SCHEMBL31211706 | 0.79 | ACE (0.41) | BTN3A1TSHRKDM4EALDH1A1CA12 | |
| SCHEMBL20181443 | 0.79 | BTN3A1 (0.35) | BTN3A1TSHRKDM4EALDH1A1CA12 | |
| SCHEMBL25475677 | 0.75 | ALDH1A1 (0.41) | TSHRALDH1A1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190276481-A1 | Liver Prodrugs of Mitochondrial Proton Ionophores | NEUROVIVE PHARMACEUTICAL AB (SE) | 2019-09-12 | — | — | US | disclosed |
| WO-2018091633-A1 | LIVER PRODRUGS OF MITOCHONDRIAL PROTON IONOPHORES | NEUROVIVE PHARMACEUTICAL AB (SE) | 2018-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190276481-A1 | Liver Prodrugs of Mitochondrial Proton Ionophores | GLS2, CYP27A1, SLC25A21 | BTN3A1 4270/4885TSHR 3287/4885KDM4E 2666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.